8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported) September 27 2004

                             BSD MEDICAL CORPORATION
             (Exact name of registrant as specified in its charter)

          Delaware                         0-10783               75-1590407
- ----------------------------             -----------           -------------
(State or other jurisdiction             (Commission           (IRS Employer
     of incorporation)                   File Number)          Identification)

                              2188 West 2200 South
                           Salt Lake City, Utah 84119
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (801) 972-5555

                                       N/A
          (Former name or former address, if changed since last report)



Item 9.01 Financial Statements and Exhibits.

      (c) Exhibits

      99.1 Press Release of BSD Medical Corporation dated September 27, 2004.

Item 7.01 Regulation FD Disclosure.

      BSD Medical Corporation issued a press release on September 27, 2004. A
copy of the press release is hereby furnished as Exhibit 99.1 attached hereto.



                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Dated: September 27, 2004

                                                          By: /s/  Hyrum A. Mead
                                                              ------------------
                                                              President



                                  EXHIBIT INDEX

Exhibit No.                          Description
- ----------    ------------------------------------------------------------------
99.1          Press Release of BSD Medical Corporation dated September 27, 2004.

EX-99.1

                                                                    Exhibit 99.1

 BSD Medical Corp. Enters China Market Through Agreement With Dalian Orientech

    SALT LAKE CITY, Sept. 28 /PRNewswire-FirstCall/ -- BSD Medical Corp.
(OTC Bulletin Board: BSDM) today announced that the company has signed an
agreement with Dalian Orientech Co. LTD to act as its distributor in the
People's Republic of China.  Hyperthermia cancer therapy has had a strong
following in China that has historically been supported by Chinese
manufactured systems.  Dalian Orientech controls about 65% of the market, with
over 1,500 installed hyperthermia systems.  Their sales force is located in
23 provinces, and is supported by a telephone staff that qualifies and grades
potential customers.  Dalian Orientech provides technical and service support
for all of its customers.

    Shu Zhi Wang, President of Dalian Orientech, said, "We are very
enthusiastic about entering into a distributorship agreement with BSD Medical
because of the demand our customers have expressed for the high-end
capabilities of the BSD-2000, and for American-made products."  Hyrum A. Mead,
president of BSD Medical said, "As the dominant distributor of hyperthermia
equipment in China, we are confident that Dalian Orientech is the most
qualified partner available to us to sell our systems into the world's largest
medical market."

    The first effort of the new distributor will be to secure Chinese
regulatory acceptance (SFDA approval) for the BSD-2000.  In China, regulatory
approval normally can be accomplished over several months of testing and
review.

    The demand for medical services is very large in China by Western
standards.  Some hospitals treat over a million patients a year.  While the
charge for the medical services required by individual patients is modest, the
heavy and efficient utilization created from a large patient volume makes the
use of high-end Western medical equipment affordable.


    BSD Medical Corporation is the leading developer of microwave systems used
in thermal medicine for the treatment of cancer.  Hyperthermia therapy is used
in combination with radiation and/or chemotherapy to boost local control of
cancer and increase long-term survival.  For more information about BSD
Medical Corp. visit www.BSDMC.com.


    Statements contained in this press release that are not historical facts
are forward looking statements, as that item is defined in the Private
Securities Litigation Reform Act of 1995.  Such forward looking statements
include the timing and ultimate regulatory acceptance of the BSD-2000 for use
in China, and the ability of the distributor to meet its sales obligations
under the distributor agreement.  All forward-looking statements are subject
to risks and uncertainties, some of which are detailed in part in the
Company's filings with the Securities and Exchange Commission.



SOURCE  BSD Medical Corporation
    -0-                             09/28/2004
    /CONTACT: BSD Medical Corporation, +1-801-972-5555, fax, +1-801-972-5930,
investor@bsdmc.com/
    /Web site:  http://www.bsdmc.com /
    (BSDM)

CO:  BSD Medical Corporation
ST:  Utah
IN:  HEA MTC BIO OTC
SU:  ASI LIC